Vector-borne diseases, including canine heartworm disease (CHWD), are of major socioeconomic and canine health importance worldwide. Although many studies have provided insights into CHWD, to date there has been limited study of fundamental molecular aspects of Dirofilaria immitis itself, its relationship with the canine host, its vectors, as well as the potential of drug resistance to emerge, using advanced -omic technologies. This article takes a prospective view of the benefits that advanced -omics technologies will have toward understanding D. immitis and CHWD. Tackling key biological questions using these technologies will provide a "systems biology" context and could lead to radically new intervention and management strategies against heartworm.
M
any vector-borne diseases have a major adverse impact on animal and human health worldwide. [1] [2] [3] A particularly important example of veterinary importance is canine heartworm disease (CHWD), caused by the filarial nematode Dirofilaria immitis. 4, 5 Despite current knowledge and developments in advanced technologies, there are still major gaps in our knowledge of many areas, including the fundamental molecular biology, molecular epidemiology, ecology and population genetics of the causative agent and its vectors, the disease itself, and also drug resistance development in D. immitis. 6, 7 Moreover, there are some limitations in diagnosis and intervention, which represent critical obstacles to the effective control of CHWD. 4, 8 Although sustained research and funding have contributed significantly to an improved understanding of vector-borne diseases of humans, [9] [10] [11] [12] this is not the case for those of veterinary importance, which are presently neglected in terms of research and development.
The revolution in molecular and computer technologies provides substantial prospects for investigating important pathogens and their vectors, providing insights into their epidemiology, ecology, evolution, and cellular processes. However, the relatively high cost and laborious nature of molecular biological research has sometimes been an impediment to progress, particularly in the veterinary field. Revolutionary developments in a range of genomic technologies 13 provide unprecedented opportunities to explore CHWD and other diseases, at a rate and on a scale unimaginable just a couple of years ago, providing enormous prospects to tackle critically important areas of research for the first time. Future research should harness such technologies to address major knowledge gaps in CHWD. Elucidating D. immitis, its relationship with its vectors and its definitive hosts, the disease itself, and the epidemiology and ecology of the parasite will have substantial implications for improving the diagnosis, treatment, prevention, and control of CHWD in years to come. This article takes a prospective view of the impact that -omic technologies could have on our knowledge and understanding of D. immitis and CHWD on the molecular level. We briefly explain the principles of transcriptomic and genomic sequencing as well as bioinformatic technologies, and describe the exciting implications of these technologies in both fundamental and applied areas.
Background on Genomic and Bioinformatic Technologies
Genomics is the study of the entire complement of genetic material (DNA or genome) in an individual organism (e.g., parasite). Transcriptomics is the molecular science of examining the transcription of all genes at the level of the cell, tissue, and/or whole organism, allowing inferences regarding cellular functions and mechanisms. The ability to explore and measure the transcription of thousands of genes simultaneously has led to major advances in all biomedical fields, from understanding basic functions in model organisms, such as Caenorhabditis elegans (a free-living nematode) and Drosophila melanogaster (vinegar fly), [14] [15] [16] [17] [18] to investigating molecular processes linked to growth, development, and reproduction, to the study of the mechanisms of survival and drug resistance. Until recently, transcriptomes have been characterized qualitatively by sequencing expressed sequence tags using conventional technologies, 19, 20 whereas levels of transcription have been assessed using complementary DNA (cDNA) microarrays 21 or real-time polymerase chain reaction (PCR). 22 In the last few years, there has been an increased demand for practical computer tools for the efficient annotation of nucleotide sequence datasets, particularly within the framework of large-scale expressed sequence tag projects. 23 
Next-generation Sequencing of Transcriptomes and Genomes
There has been a massive expansion in next-generation sequencing (NGS) technologies, 24-27 which now provide unique opportunities to explore de novo the transcriptomes and nuclear genomes of different species, strains and developmental stages of D. immitis as well as its vectors and its canine or other definitive hosts. The capacity of NGS techniques to generate millions to hundreds of millions of sequences, in parallel, has put them at the forefront of the scientific research. 28Ϫ30 NGS technologies include 454 (Roche), 24 SOLiD, 27 and Illumina/HiSeq. 25 For example, the 454 technology platform 24 uses a sequencing-by-synthesis approach, by which cDNA is randomly fragmented into 500 to 1000 base pair fragments. During the process of cDNA library construction, an adaptor is ligated to each end of these fragments and then mixed into a population of agarose beads whose surfaces anchor oligonucleotides complementary to the 454-specific adapter sequence, such that each bead is linked to a single fragment. Each of these complexes is transferred into individual oil-water micelles containing amplification reagents and then subjected to an emulsion PCR step, during which ϳ10 million copies are produced and bound to individual beads. In the sequencing step, the beads anchoring the cDNAs are deposited on a picotitre plate, together with other enzymes required for the pyrophosphate sequencing reaction on a solid support system. 31 The 454 technology (a "longread" platform) has been used frequently for de novo genomic or transcriptomic studies. However, increasingly, Illumina/HiSeq is being used for this purpose. This latter technology differs significantly from the 454 approach, 25 in that, after fragmentation of cDNA, Illumina-specific adaptors are ligated to each cDNA template and then covalently attached to the surface of a glass slide, allowing individual templates (cDNAs) to form bridge-like structures. During the amplification step (bridge PCR), clonal clusters of ϳ1000 amplicons are generated and immobilized to a single physical location on the slide. Then the cDNAs are linearized, and the sequencing reagents (including 4 fluorescently labeled nucleotides) are added to the flow cell. After the individual fluorescent bases have been incorporated, the flow cell is interrogated with a laser beam in several locations, allowing several image acquisitions at the end of a single synthesis cycle, and the sequences to be read. 31 This technology is considered ideal for resequencing projects, targeted sequencing, single nucleotide polymorphism analyses, and gene transcription studies.
In the last years, numerous studies have shown the utility of NGS technologies for investigating, for example, aspects of the molecular biology, systematics, and population genetics of parasites. [32] [33] [34] [35] In particular, 454 technology has been used recently for the rapid de novo sequencing of the transcriptomes of numerous pathogens of veterinary and human health importance, 33-41 yielding substantial datasets and providing a major step forward in the understanding of the basic molecular biology of these organisms.
Bioinformatic Tools (ϭ Computer Programs) for the Analysis of NGS Datasets
The development of practical and efficient bioinformatic tools has become critical for comprehensive analyses of DNA, RNA and protein sequence data as well as for making biological sense of such datasets. Therefore, there has been relatively rapid progress in the construction of new programs and/or integrated pipelines, some of which are accessible via the Worldwide Web. [42] [43] [44] [45] [46] The principles, methods and protocols for the analysis of sequence data, together with currently available bioinformatic tools and pipelines, have been reviewed recently. 47 In brief, after the acquisition of data, nucleotide sequences are firstly screened for repeats, contaminants and/or adaptor sequences, 47, 48 and "clustered" (assembled) into contiguous sequences (of maximum length; called contigs) based on sequence similarity. 47 Long reads (produced by 454 or conventional sequencing technologies) and short reads (e.g., Illumina) are assembled using the algorithms "overlap-layoutconsensus" 49 and "de Bruijn graph," 50, 51 respectively. For the former algorithm, 49 pairwise overlaps among reads are computed and stored in a graph; the graphs are used to compute a layout of reads and then a consensus sequence of contigs. 42, [52] [53] [54] [55] [56] [57] For the de Bruijn graph, 50, 51 reads are fragmented into short segments, called "k-mers" (number of nucleotides in each segment; overlaps among k-mers are captured and stored in graphs, which are then used to produce consensus sequences. 51, [56] [57] [58] [59] [60] After assembly, the contigs and single reads (singletons) are compared, using different types of the Basic Local Alignment Software Tool (BLAST), 61 with known sequence data available in public databases, to infer an identity for each query sequence, if significant matches are found. 47 In addition, assembled nucleotide sequences are usually conceptually translated into pre-dicted proteins with algorithms that identify protein-coding regions from individual contigs. 43, 62, 63 Protein analyses, including amino acid sequence comparisons with data available in public databases, are then conducted. 44, 46, 47, [64] [65] [66] [67] Public databases online represent comprehensive collections of amino acid and nucleotide sequences [68] [69] [70] ; sequences are stored together with relevant information, including primary references, and predicted and/or experimental data. For transcriptomic datasets, examples of databases include the Sequence Read Archive 71 and UniGene. 72 In addition, there are various specialized collections of gene and protein data on organisms about which much is known. Examples include the databases for C. elegans (WormBase at http://www.wormbase.org) 73, 74 and D. melanogaster (http://flybase.org). 75 The data generated by NGS technologies are often gigabytes to terabytes in size, substantially increasing the demands placed on data transfer, analysis, and storage. For instance, to circumvent this limitation somewhat, we recently constructed an integrated bioinformatic workflow system for the efficient analysis and annotation of large NGS datasets. This platform, which is presently accessible via http:// research.vet.unimelb.edu.au/gasserlab/index.html, has proved very effective and time efficient for distilling biologically relevant molecular information from large NGS datasets for pathogens of veterinary importance.
Opportunities and Challenges
Knowledge of the transcriptomes, genomes, and proteomes of D. immitis, its vectors, and its definitive host is central to gaining an enhanced understanding of the molecular mechanisms that govern essential biological as well as infection and disease processes and, ultimately, could assist in identifying possible mechanisms of drug resistance and avenues for the development of radically new intervention strategies. Detailed and accurate analyses of nucleic acid and protein sequence data, usually by comparison with reference organisms, are crucial in providing biologically meaningful information on the organisms under study. Until recently, detailed bioinformatic analyses of such data have been restricted largely to specialized laboratories with substantial computer and software capacities. However, increasingly flexible and practical bioinformatic workflow systems are becoming available to assist scientists in their analyses of massive NGS datasets.
Although the draft genome Brugia malayi (a filarioid related to D. immitis) is available 76 and should provide a useful reference for comparative analysis, transcriptomic and genomic sequence data for D. immitis will need to be assembled de novo. This would mean that pooled sequence reads must be assembled without a bias toward known sequences. 51 Because of the amount of RNA required for NGS (ϳ5-10 g), 77 transcriptomes are usually derived from multiple organisms (in this case, worms), which have the potential to lead to possible polymorphism in the sequence data acquired (linked, for instance, to a biased nucleotide content, single nucleotide polymorphisms 6 and other types of sequence variation within or among worms), and pose challenges for data assembly. In addition, reliable de novo assemblies are dependent on the availability of long reads (Ͼ 100 bases) and/or of high-coverage, paired-end sequence data. 78 In previous studies, the combined use of 454 and Illumina sequencing platforms has enabled the assembly of raw reads into large scaffolds, without a need for a reference sequence. [79] [80] [81] The accurate assembly of sequence data is a crucial step in examining coding genes and, subsequently, in addressing biological questions regarding gene and protein functions. Functions are initially predicted by "sequence annotation" (ϭ the process of gathering all available information and relating it to the sequence assembly both by experimental and computational means). 82 Reliable annotation is dependent on the efficiency of the updates and curation of data. Presently, public databases for bioinformatic analyses and annotation of sequence data are accessible via multiple portals, and there is considerable variation in the rate at which public databases are updated and corrected. In addition, some information-management systems incorporate data from largescale projects, but often the annotation of single records from the literature is slow. 83 Given that, presently, the annotation of sequence data for parasites and vectors relies heavily on the use of bioinformatic approaches and already annotated/ curated sequence data for a wide range of organisms, these aspects need to be considered.
The annotation of peptides inferred from a dataset is conducted by assigning predicted biological function(s) by comparisons with information in public databases, including InterPro (www.ebi.ac.uk/interpro/), Gene Ontology (www. geneontology.org/), OrthoMCL (www.orthomcl.org/), and BRENDA (www.brenda-enzymes.org/). Using this approach, together with knowledge of the B. malayi genome, 76 inferences can be made regarding the function and essentiality of key groups of molecules involved in biological processes in D. immitis. Such groups include molecules linked to reproduction, development, signal transduction, and/or disease processes (e.g., proteases and protease inhibitors, protein kinases, and phosphatases) 36-39,84 as well as the physiology of the nervous system 37 and the formation of the cuticle (nematodes). 37, 85 The bioinformatic prediction and prioritization of new drug targets involves "filtering" 86, 87 and usually includes inferring targets based on key requirements and principles. [88] [89] [90] [91] [92] First, target proteins should have one or more crucial (essential) roles in fundamental biological processes of the pathogen and/or vector, such that the disruption of the molecule or its gene will damage and/or kill both or either and thus disrupt disease transmission or disease itself, but not adversely affect the host. 91, 93 Presently, for parasitic nematodes, the inference of drug target candidates is mostly assisted through the use of extensive information on function and essentiality in a range of eukaryotic organisms, including C. elegans (WormBase at http://www.wormbase.org). Because most effective drugs achieve their activity by competing with endogenous, small molecules for a binding site on a target protein,
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the amino acid sequences predicted from essential genes should be screened for the presence of relatively conserved ligand-binding domains. 94, 95 Lists of inhibitors, known based on experimental evidence, to specifically bind to such domains, can be compiled. However, the predictions made are intended to support hypothesis-driven or applied research and thus require extensive experimental validation. The challenge for D. immitis is its long, indirect life cycle and the time, cost, and labor involved in producing different stages of the parasite for molecular investigations. Moreover, the parasite cannot be produced or maintained for long periods of time in culture in vitro, which makes the in vitro testing of gene function (as is routinely performed for C. elegans) 96 challenging. Nevertheless, assays are available for some developmental stages, such as microfilariae, 97 which might allow functional genomic studies to be conducted in the parasite itself.
Many Implications in Fundamental and Applied Areas
Although various studies have given improved insights into the epidemiology of D. immitis using molecular methods, [98] [99] [100] there has been very limited study of fundamental molecular biology of this parasite, its vectors, and its relationship with the mammalian host and CHWD as well as possible drug or insecticide resistance with advanced -omic technologies. Using modern genomic (NGS) and bioinformatic technologies to understand the systems biology of D. immitis and CHWD should lead to the design of radically new intervention and management strategies against D. immitis.
For example, from a fundamental viewpoint, genomewide sequencing and the definition of a wide range of genetic markers for use in specific and sensitive diagnostic tools could provide a solid foundation for addressing questions regarding the complex network of biological and ecological factors involved in parasite-vector-host-environment interactions and the immunological idiosyncrasies of receptive hosts in endemic regions as well as the role of asymptomatic, chronically infected animals and those infected with multiple pathogens. 2 It would also be very useful to investigate the resistance and susceptibility of, for example, particular breeds, haplotypes, or genotypes of dogs to D. immitis and its vectors. For instance, elucidating the relationship between host genotype and phenotype (degree of disease expression) in response to CHWD and/or intervention approach (e.g., treatment or vaccination) would be particularly informative and could provide a profound understanding of the genetic basis of disease. From an epidemiological perspective, changes in the temporal and spatial distribution of D. immitis, vectors, and/or their hosts, as a result of climatic change and global warming, might also be monitored with metagenomic approaches. 101 Obviously, another question of major importance is whether D. immitis is developing genetic resistance against macrocyclic lactones, which have been routinely used (over many years), particularly in the United States, parts of Europe, and Australia, to prevent CHWD. Although it was originally proposed that D. immitis is highly unlikely to develop resistance against such compounds, 102 there is now some recent genetic and experimental evidence 6, 7 indicating that some populations of this nematode are less susceptible to macrocyclic lactones than others, which suggests an emergence of genetic resistance against this class of compounds. 97 After the determination of a reference genome for D. immitis, it will be possible, using NGS, to genetically compare multiple populations of adult worms indicated to be resistant or susceptible to one or more macrocyclic lactones (via the testing of microfilariae from the blood from infected dogs), 7 and then to establish a clear link between a drug-resistant phenotype and its genotype on a genome-wide scale. Transcriptomic analyses could be used to underpin genomic comparisons by providing evidence of differential transcription of genes (upregulation or downregulation) between resistant and susceptible worms (e.g., after the treatment of microfilariae with sublethal doses of macrocycline lactone). Ultimately, establishing genomic differences would allow the definition of genetic markers that could then be used in a molecular test for the direct and specific molecular detection of drug-resistant worms (via DNA from microfilariae or adult worms) in the blood from infected dogs in endemic regions in which preventative treatment is routinely or commonly used. Clearly, these examples indicate that there are many exciting fundamental areas and questions to tackle using modern genomic tools.
From an applied perspective, the prediction and prioritization of drug targets in D. immitis or repellants against vectors is another area of major importance. NGS will provide the efficiency and depth of coverage required to rapidly define de novo the complete genomes of D. immitis, vectors and canine and other hosts. Repertoires of drug targets could be inferred on a genome-wide scale. For instance, the D. immitis kinome (the complete set of kinase genes in the genome) could represent a unique opportunity for the design of pathogen-selective inhibitors 103 for subsequent validation by high throughput screening. [104] [105] [106] [107] Other targets, such as guanosine triphosphatases and protein phosphatases, 103, 108, 109 might also represent attractive drug target candidates for D. immitis, but have not yet been examined in a systematic manner or on a large scale.
In conclusion, the combined use of genomic, transcriptomic, and proteomic datasets will be central to identifying other groups of molecules essential to the development and survival of D. immitis and will pave the way for the design of novel classes of small molecular inhibitors. Clearly, an integrated use of -omic technologies will enable investigations of the systems biology of D. immitis and CHWD on a scale never before possible and will provide unprecedented opportunities for the development of entirely new intervention and diagnostic strategies. The ability to explore heartworm in this way will also open up numerous opportunities to investigate key filarioid nematodes of humans and other animals. Volume 26, Number 4, November 2011
